| Identification | |
| Name: | b-D-Glucopyranosiduronic acid, (5a,7a)-17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-7-[(1S)-1-hydroxy-1,2,2-trimethylpropyl]-6-methoxy-6,14-ethenomorphinan-3-yl |
| Synonyms: | Buprenorphine-3-glucuronide;Buprenorphine-3-b-D-glucuronide |
| CAS: | 101224-22-0 |
| Molecular Formula: | C35H49 N O10 |
| Molecular Weight: | 0 |
| InChI: | InChI=1/C35H49NO10/c1-31(2,3)32(4,42)21-15-33-8-9-35(21,43-5)30-34(33)10-11-36(16-17-6-7-17)22(33)13-18-12-19(14-20(45-30)23(18)34)44-29-26(39)24(37)25(38)27(46-29)28(40)41/h12,14,17,21-22,24-27,29-30,37-39,42H,6-11,13,15-16H2,1-5H3,(H,40,41)/t21-,22-,24+,25+,26-,27+,29-,30-,32+,33-,34+,35-/m1/s1 |
| Molecular Structure: |  |
| Properties | |
| Flash Point: | °C |
| Boiling Point: | °Cat760mmHg |
| Density: | 1.43g/cm3 |
| Refractive index: | 1.657 |
| Flash Point: | °C |
| Usage: | A metabolite of Buprenorphine. Controlled substance |
| Safety Data | |
 |
|
